FAF
SLXP

Fjarde Ap-fonden’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Fjarde Ap-fonden’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-19,409
Closed -$3.35M – 653
2015
Q1 		$3.35M Hold
19,409
– – 0.08% 305
2014
Q4 		$2.23M Buy
+19,409
New +$2.35M 0.05% 471

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Fjarde Ap-fonden's SLXP Position: Q2 2015 in Review

Fjarde Ap-fonden sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 19,409 shares — an estimated $3.35M sold.

Fjarde Ap-fonden first reported a position in SLXP in Q4 2014 and held it in 2 quarters. The position peaked at $3.35M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Fjarde Ap-fonden reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Fjarde Ap-fonden sold 19,409 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $3.35M.
  • Fjarde Ap-fonden first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2014 and held it in 2 quarters.
  • Fjarde Ap-fonden's SALIX PHARMACEUTICALS LTD DEL position peaked at $3.35M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Fjarde Ap-fonden's 13F filing for Q2 2015, filed 24 Jul 2015.